These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7917528)

  • 1. Interlaboratory comparison of oestrogen receptor data.
    Thorpe SM
    Eur J Cancer; 1994; 30A(6):730-2. PubMed ID: 7917528
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences.
    Romain S; Formento JL; Guirou O; Francoual M; Milano G; Martin PM
    Eur J Cancer; 1994; 30A(6):740-6. PubMed ID: 7917530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems.
    Rhodes A; Jasani B; Barnes DM; Bobrow LG; Miller KD
    J Clin Pathol; 2000 Feb; 53(2):125-30. PubMed ID: 10767828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in rates of oestrogen receptor positivity in breast cancer again.
    Miller K; Rhodes A; Jasani B
    BMJ; 2002 Feb; 324(7332):298. PubMed ID: 11823372
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid receptor assays: an Italian quality assessment program.
    Piffanelli A; Giovannini G; Pelizzola D; De Bortoli M; Catozzi L; Giganti M
    Ann Ist Super Sanita; 1991; 27(3):523-9. PubMed ID: 1809075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for bimodal distribution of breast carcinoma ER and PgR values quantitated by enzyme immunoassay.
    Mobbs BG; Chapman JA; Sutherland DJ; Ryan E; Tustanoff ER; Ooi TC; Murthy PV
    Eur J Cancer; 1993; 29A(9):1293-7. PubMed ID: 8343271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of oestrogen receptors by enzyme immunoassay.
    Weigand RA; Lynch D; Cotter D
    Eur J Cancer; 1994; 30A(6):888. PubMed ID: 7917554
    [No Abstract]   [Full Text] [Related]  

  • 8. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.
    Detre S; Saclani Jotti G; Dowsett M
    J Clin Pathol; 1995 Sep; 48(9):876-8. PubMed ID: 7490328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma.
    Fox SB; Rogers S; Day CA; Underwood JC
    J Pathol; 1992 Jan; 166(1):13-8. PubMed ID: 1538271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer.
    Cappelletti V; Coradini D; Scanziani E; Benini E; Silvestrini R; Di Fronzo G
    Eur J Cancer; 1992; 28A(8-9):1315-8. PubMed ID: 1515241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the pS2 peptide in primary breast carcinomas: comparison of membrane and cytoplasmic staining patterns.
    Dookeran KA; Rye PD; Dearing SJ; Walker RA
    J Pathol; 1993 Oct; 171(2):123-9. PubMed ID: 8283349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guideline for testing of estrogen and progesterone receptors in breast cancer].
    Guideline Recommendations for Immunohistochemistry Detection in Breast Cancer Group
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):237-9. PubMed ID: 25975904
    [No Abstract]   [Full Text] [Related]  

  • 13. The expression of c-fos protein in human breast.
    Walker RA; Cowl J
    J Pathol; 1991 Apr; 163(4):323-7. PubMed ID: 1903442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.
    Romain S; Lainé Bidron C; Martin PM; Magdelenat H
    Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibodies in the immunohistochemical detection of estrogen and progesterone receptor status in breast carcinoma].
    Shui R; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):229-31. PubMed ID: 25975902
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of oestrogen receptor by enzyme immunoassay.
    Hyder SM
    Eur J Cancer; 1995; 31A(5):852-3. PubMed ID: 7640084
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing.
    Sannino P; Shousha S
    J Clin Pathol; 1994 Jan; 47(1):90-2. PubMed ID: 8132819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between anxiety parameters and oestrogen receptor status in early breast cancer.
    Rosenqvist S; Berglund G; Bolund C; Fornander T; Rutqvist LE; Skoog L; Wilking N
    Eur J Cancer; 1993; 29A(9):1325-6. PubMed ID: 8343278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.
    Parker RL; Huntsman DG; Lesack DW; Cupples JB; Grant DR; Akbari M; Gilks CB
    Am J Clin Pathol; 2002 May; 117(5):723-8. PubMed ID: 12090420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    J Clin Pathol; 2007 Apr; 60(4):397-404. PubMed ID: 16775123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.